Monarch Partners Asset Management LLC Adverum Biotechnologies, Inc. Transaction History

Monarch Partners Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$2.87 - $5.92 $171,898 - $354,578	-59,895 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$4.5 - $7.6 $62,910 - $106,248	13,980 Added 30.45%	59,895 $362,000
Q2 2018 Aug 07, 2018	BUY	$5.3 - $6.9 $47,700 - $62,100	9,000 Added 24.38%	45,915 $243,000
Q1 2018 Apr 30, 2018	BUY	$3.65 - $7.95 $134,739 - $293,474	36,915 New	36,915 $214,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Monarch Partners Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monarch Partners Asset Management LLC with notifications on news.